Continuous research monitoring improves the quality of research conduct and compliance among research trainees: internal evaluation of a monitoring programme. by Akello, Mirriam et al.
RESEARCH ARTICLE
Continuous research monitoring improves the quality of 
research conduct and compliance among research trainees: 
internal evaluation of a monitoring programme [version 1; 
peer review: awaiting peer review]
Mirriam Akello 1,2, Sarah Coutinho2, Mary Gorrethy N-Mboowa 2, 
Victoria D Bukirwa2, Agnes Natukunda1, Lawrence Lubyayi1, 
Grace Nabakooza 2-4, Stephen Cose 1,2,5, Alison M. Elliott 1,2,5
1Medical Research Council/Uganda Virus Research Institute and London School Hygiene Tropical Medicine Uganda Research Unit, 
Entebbe, Uganda 
2Makerere University/ Uganda Virus Research Institute Centre of Excellence in Infection and Immunity Research and Training (MUII-
Plus), Uganda Virus Research Institute, Entebbe, Uganda 
3Department of Immunology and Molecular Biology, Makerere University, Kampala, Uganda 
4Centre for Computational Biology, Uganda Christian University, Mukono, Uganda 
5Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK 
First published: 25 Nov 2020, 3:57  
https://doi.org/10.12688/aasopenres.13117.1




Background: Research site monitoring (RSM) is an effective way to 
ensure compliance with Good Clinical Practice (GCP). However, RSM is 
not offered to trainees (investigators) at African Institutions routinely. 
The Makerere University/Uganda Virus Research Institute Centre of 
Excellence in Infection and Immunity Research and Training (MUII-
Plus) introduced internal monitoring to promote the quality of 
trainees’ research projects. Here, we share our monitoring model, 
experiences and achievements, and challenges encountered. 
Methods: We analysed investigators’ project reports from monitoring 
visits undertaken from April 2017 to December 2019. Monitors 
followed a standard checklist to review investigator site files and 
record forms, and toured site facilities. We planned four monitoring 
visits for each trainee: one at site initiation, two interim, and a 
closeout monitoring visit. A team of two monitors conducted the 
visits. 
Results: We monitored 25 out of the 26 research projects in progress 
between April 2017 and December 2019. Compliance with protocols, 
standard operating procedures, GCP, and GCLP improved with each 
monitoring visit. Median (IQR) compliance rate was 43% (31%, 44%) at 
site initiation visit for different monitoring items, 70% (54%, 90%) at 
the 1st interim monitoring visit, 100% (92%, 100%) at 2nd interim 
monitoring visit and all projects achieved 100% compliance at site 
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closeout.  All investigators had good work ethics and practice, and 
appropriate facilities. Initially, some investigators’ files lacked essential 
documents, and informed consent processes needed to be improved. 
We realized that non-compliant investigators had not received prior 
training in GCP/GCLP, so we offered them this training. 
Conclusions: Routine monitoring helps identify non-compliance early 
and improves the quality of research. We recommend continuous 
internal monitoring for all research studies. Investigators conducting 
research involving human subjects should receive GCP/GCLP training 
before commencing their projects. Institutional higher degrees and 
research ethics committees should enforce this as a requirement for 
project approvals.
Keywords 
Internal monitoring, Good Clinical Research Practice, trainees or 
investigators, Uganda, Africa, research quality
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Background
Research site monitoring (RSM) is a systematic process that 
involves the close supervision of an investigator to ensure 
that all research activities are implemented according to the 
approved study protocols and good clinical practice (GCP).
All studies that involve humans subjects must be reviewed 
ethically and scientifically before their start1–5 and monitored 
as per international human research regulatory guidelines4. 
Research Ethics Committees are critical in giving independent 
corrective review of proposed studies to ensure that the dignity 
and wellbeing of potential participants are fully protected1. 
These committees review study tools such as consent and data 
collection forms and laboratory and data analysis protocols, to 
ensure that they align with GCP and Good Clinical Laboratory 
Practice (GCLP) guidelines4,6.
Research site initiation procedures and routine monitoring 
of ethically approved human studies are essential to ensure 
that all investigators are qualified and competent to undertake 
the proposed work, required study facilities and tools are avail-
able, participants’ rights and safety are protected during data 
collection, and data is collected accurately to produce reliable 
results4. Additionally, continuous monitoring prevents research 
fraud, minimizes un-ethical practices, enables early detec-
tion of protocol deviations, and ensures rightful and effective 
dissemination of research results4,6,7.
The Makerere University/Uganda Virus Research Institute 
Centre of Excellence in Infection and Immunity Research and 
Training (MUII-Plus) is a program under the African Academy of 
Sciences DELTAS Initiative, whose goal is to promote scientific 
quality and to train future research leaders for excellence (www.
muii.org.ug). The MUII-Plus umbrella supports trainees (inves-
tigators) including undergraduates, postgraduates, post-doctoral 
fellows, and emerging research leaders.
At the start of the MUII-Plus programme, we realised that a 
number of trainee investigators had limited knowledge of pro-
cedures governing research and how to conduct their projects 
correctly. To equip the investigators with the necessary skills and 
promote scientific quality, MUII-Plus launched routine monitor-
ing of research sites and activities for all their investigators in 
April 2017. 
In this paper we present a model for internal monitoring of 
trainee investigators’ research projects that we have found achiev-
able and effective in a local academic research setting. We 
believe this model can be adopted by other training programmes 
to benefit and support the progress of their investigators.
Methods
Site monitoring processes
Routine monitoring of research projects for all MUII-Plus 
investigators commenced in April 2017 to date. This involves 
internal monitors reviewing and evaluating investigators’ research 
sites and projects based on a standard checklist (Table 1). 
In this study, we report findings for monitoring done between 
April 2017 and December 2019.
Four monitoring visits were planned for each research project; 
site initiation (SIV), two interim (IMV), and a closeout moni-
toring visit (CMV). A team of two (MA and SC) conducted 
the monitoring visits. MA, a registered midwife, worked as 
a research nurse for nine years, then trained as a clinical trial 
monitor in 2011 under the East African Consortium for Clini-
cal Research (EACCR), and was certified as a Clinical Research 
Associate (CRA) in 2017 by African Clinical Research Organi-
sation (ACRO); she is experienced in monitoring observational 
studies and clinical trials. MA was assisted by SC, a registered 
nurse with a 15-year experience; SC also trained as a Clinical 
Trial Monitor under EACCR.
For each new study, the monitors and investigator (trainee) 
discussed, planned, and shared a list of essential documents 
to be reviewed at least a week before the first monitoring 
referred to as the site initiation visit (SIV). Once the SIV date 
was confirmed, the monitors sent a monitoring agenda to the 
investigator before the visit.
Site initiation visit (SIV)
The SIV was to establish research sites and facilities to ensure 
investigators had all the necessary approvals, qualified and 
skilled staff, data collection tools and documents, and laboratory 
materials to implement the proposed research project.
During this visit, the investigator was asked to share and explain 
his or her project proposal, clinical, laboratory, or pharmacy 
procedures as applicable, and data management plan. Simi-
larly, the monitors informed investigators about the purpose 
of the monitoring, the monitors’ and investigator’s responsi-
bilities, informed consent procedures, and good documentation 
practices. Additionally, the monitors critically verified the inves-
tigator’s site file (ISF) which comprised of academic docu-
ments, approved protocols, valid practicing licenses, GCP, and 
GCLP certificates for staff as applicable (Table 1). In case of any 
queries, the investigator was given time to address them and a SIV 
follow-up visit was done for corrective action before the 
project commenced.
Interim monitoring visit (IMV)
The IMV followed the SIV intending to review the progress 
of the commenced project. First, the monitor checked whether 
the investigator screened and enrolled participants, collected, 
documented, and managed data as described in the approved 
standard operating procedures (SOPs) and protocols. For data 
management, the monitor verified that the completed data 
collection forms or source data matched that entered in the data-
base and backed up routinely. Second, the research site was toured 
to ensure adequate and proper use of research materials, proce-
dure rooms, and storage facilities for specimens and samples, 
documents and drugs as applicable. The IMV was concluded 
with a discussion on the key issues identified and the investiga-
tor was advised on the appropriate action to address the issues, 
as the investigator awaited a detailed visit report.
Study closeout monitoring visit (CMV)
The CMV was performed at the end of the research project 
when all study participants’ visits and follow-up were complete 
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and all data collected as required. Here, the monitor revisited 
the ISF, consent forms, data collection forms, and databases, 
to ensure that all were complete. In addition, the monitor and 
investigator planned for proper storage of study documents and 
samples to enable easy retrieval for future use.
Monitoring report
After each visit, a written report was shared with the investiga-
tor and his or her supervisors for review and signing. Then the 
monitor co-signed the final report and shared it with the investi-
gator, MUII-Plus programme centre manager and director. In 
case of any critical findings that could not be resolved between 
the trainee and monitor, the director or centre manager would 
have meetings and discuss the way forward with the investigator.
Model used to review the monitoring reports
To assess compliance of MUII-Plus investigators to Good Clini-
cal Practice, the monitoring team considered six elements: 
(1) regulatory documents, (2) informed consent process and 
documentation, (3) protocol adherence and Source data verifica-
tion (SDV), (4) study-related training, (5) working practices and 
(6) tour of project site facilities (Table 2).
Regulatory documents are guidelines that the monitor uses to 
keep the investigator within the legal and ethical boundaries 
during their research projects, and assess the research conduct 
and quality of data generated. These included approved protocols 
and consent documents, data collection forms, curriculum vitae, 
academic documents and others, as described in (Table 2).
Obtaining informed consent from participants is very important 
in the ethical process of human research. This process requires 
that the investigator respects and protects the rights of the 
participants by thoroughly explaining the research objectives and 
expected requirements from participants before obtaining their 
consent. All participants sign and date on the consent form as 
proof of their consent to enroll in the research. After this, a copy 
of the form is shared with the participant. Throughout the project, 
the investigator and participant maintain information exchange, 
and the participants reserve the right to withdraw their consent.
Protocol adherence and source data verification requires that 
the investigator adheres to the approved protocols to ensure 
data generated and captured is accurate and complete.
An investigator and their staff must undergo thorough training 
on different aspects of the proposed research project, 
including GCP/GCLP guidelines and SOPs, so that they are com-
petent in their work. Often, members are awarded certificates 
on completion of the trainings which they put on file.
Evaluation of working practices involves assessment of team-
work and coordination between research investigators and 
staff for effective communication and implementation of the 
research project. For example, tracking the number of times 
trainee investigators meet their supervisors and checking 
whether meeting minutes are on file. All these aspects were 
evaluated based on whether documentation was present at each 
site visit.
Data extraction and analysis
We extracted data on components monitored from the approved 
and signed off monitoring reports from each visit. The data 
was entered into an excel spreadsheet with each variable 
representing an item in Table 2. For each project, a score of one 
(1) was assigned to each item if its documentation/facility was 
present and zero (0) otherwise. An average score was obtained 
and converted into a percentage compliance for every visit. 
We used Stata version 15.0 (StataCorp, College Station, USA) 
for analysis.
Ethics and consent
This report describes the findings of an internal evaluation under-
taken to support learning, following the implementation of 
internal monitoring to enhance the quality of work undertaken 
by research trainees. The work was reviewed by the Research 
Ethics Committee of the Uganda Virus Research and a determi-
nation of “non-research”, waiving the requirement for ethical 
review and approval, was made. All the investigators gave writ-
ten permission for the reports on their work to be used for 
this evaluation and publication.
Results
We reviewed documents and reports for masters, PhD, and post-
doctoral fellows’ projects running between April 2017 and 
December 2019. During this period, there were 26 research 
projects, and we monitored 25 (96.2%) of these. Of the 
monitored studies, 18 underwent a site initiation visit (SIV), 12 
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(IMV), 5 had a second IMV, and 8 had a closeout monitor-
ing visit (CMV) by the time of analysis. Some studies did not 
have all monitoring visits because they started earlier than the 
monitoring programme (Figure 1).
Regulatory documents
During the SIV, 43% of the projects were compliant based on 
regulatory documents. The compliance was lower than expected 
because investigators had not obtained project or protocol 
approvals from the different Research Ethics Committees 
at the time of analysis. One study lacked regulatory docu-
ments on file, and it was hard to determine whether it had valid 
approvals and was compliant in other administrative aspects. 
At this time, none of the projects that planned to ship biological 
samples had obtained the material transfer agreements (MTA) 
required. We also observed poor documentation practice: for 
instance, many investigator files did not have a table of con-
tents, and it was difficult for the monitor to identify and 
access filed records quickly.
However, the compliance improved to 77% at the time of 
the SIV follow-up visit. There was an improvement of 92% 
and 100% during the second interim and final closeout visits, 
respectively (Table 38).
Informed consent process and documentation
There was 44% compliance with the informed consent proc-
ess and documentation at SIV. Sometimes essential documents 
Table 2. General Monitoring Activities conducted for all the four visits.
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such as the informed consent forms were still being devel-
oped or under consideration by the ethics committees. Compli-
ance levels increased during the following monitoring visits, 
75% at SIV follow-up and 93% at first IMV. At these visits a 
few projects had incomplete or missing consent forms and in 
some cases research staff had signed as witness for participants 
(contrary to good practice). 
By the second IMV and CMV, all projects (100%) were compliant 
with complete consent forms and documentation (Table 3). 
Protocol adherence and source data verification (SDV)
Overall, the majority of the investigators adhered to their 
research protocols and standard operating procedures, and 
data collected was accurate and complete.
Figure 1. Projects monitored at each monitoring visit.
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Study-related training
Only 31% of investigators had evidence of study-related train-
ings at the SIV because most of them had not received train-
ing on GCP/GCLP guidelines and SOPs. On subsequent 
monitoring, 75% and 54% of investigators and their staff had 
been trained and certified at the SIV follow-up and first IMV, 
respectively. Towards the last monitoring visits, we achieved 
100% compliance (Table 3).
Working practices
Under working practices, compliance was 28% at the SIV and 
improved to 50% at both the SIV follow-up and first IMV. 
Some investigators had held and documented study-related 
meetings regularly. A few had no meetings at all at SIV. Dur-
ing the second IMV and CMV, full compliance of (100%) were 
recorded (Table 3).
Tour of project site facilities
While carrying out the tour of project site facilities, the moni-
tors focused on the clinic room, laboratory process area, data 
management area, study reagents and materials availability, 
storage facilities for specimens collected, and study drugs.
The majority of the research sites had facilities that were ade-
quate to conduct the studies. The facilities complied with the 
minimum standards described in Table 2 at 81% during the 
site initiation visit and above 90% for the subsequent monitor-
ing visits (Table 3). However, we noted congestion at participant 
recruitment stations.
Challenges encountered by monitors
The monitors encountered logistical delays from investiga-
tors in confirming appointments for monitoring, reviewing 
and giving feedback on monitoring reports, and addressing 
monitoring issues raised.
Discussion
We have presented an internal evaluation of the MUII-Plus 
research monitoring programme. Our findings show that many 
trainee investigators, and their research teams, needed training 
in good clinical research practice – to an extent that we had 
not recognised at the start of our programme. Through inter-
nal monitoring, we recognised the needs of investigators 
and trained them, which improved their compliance with the 
research guidelines. We believe that these findings highlight 
a critical training need, and we present a monitoring model 
that could contribute to advancing research excellence across 
Africa.
The reviewed reports emphasized the need for investigators 
to pay close attention to the regulatory requirements, espe-
cially ethical approvals for their research projects, and the 
monitors to carry out a pre-site assessment visit to minimize 
non-compliance observed during the site initiation visits. Our 
findings reflect experience across the continent: in one example, 
only 9.8% of student dissertations on HIV across universities in 
Cameroon9 documented ethical approvals. There is a need to 
address the lack of knowledge in both students and their men-
tors about principles guiding human research, and requirements 
for documentation of approval processes.
Informed consent is an aspect of ethical human research that 
needs keen attention. A study done in Uganda between 2007 
and 2010 showed that 36% of research sites violated the 
informed consent process7. We found that, at first, the informed 
consent process was not adequately practiced by some inves-
tigator trainees in the MUII-plus programme: some projects 
had incomplete consent forms, project staff signed as wit-
nesses for participants, signed copies were not given to 
participants, and occasionally forms were missing. However, our 
continuous monitoring showed improved compliance up to 
Table 3. Performance of investigators at each monitoring visit.
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44 75 93 100 100
 3.  Study related training  31 75 54 90 100
 4.  Working practices 28 50 50 100 100
 5.  Tour of project site facilities 81 92 90 100 100
Average compliance across 
all domains
45 73 71 96 100
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100% at the second IMV and CMV. The marked improve-
ment observed in our study implies that consent processes dur-
ing investigators’ projects can be improved by prior training and 
sensitization of investigators and their study teams and frequent 
monitoring.
During the site initiation visit, compliance in terms of pro-
viding research teams with study-related training and adopt-
ing good working practices, such as regular team meetings, 
was low, 31% and 28%, respectively. Here, GCP/GCLP certifi-
cates and protocol training logs for team members, and minutes 
for supervision or team meetings, were lacking. This low 
compliance was because the trainee investigators lacked knowl-
edge on the kind of team trainings they were supposed to under-
take. This prompted the MUII-Plus programme to fully fund 
face-to-face GCP/GCLP training for all investigators and their 
teams in 2017 and 2018. Following the first training, all investi-
gators undertake a refresher online GCP/GCLP training, such 
as the course hosted by the Global Health Training Centre 
(GHTC)10, every two years. Investigators must learn the impor-
tance of providing protocol and SOP training for their team 
before research work commences, and be involved in team-
building activities and regular team meetings to maintain effec-
tive communication and implementation during the research 
activities.
Site facilities for our trainees were found to be relatively ade-
quate concerning clinic rooms, laboratory process areas and data 
management areas, study reagents and materials availability, 
and storage facilities for specimens collected and study drugs. 
Not surprisingly, given the setting of busy African hospitals 
and clinics, a good number of investigators faced the challenge 
of congestion at recruitment locations, due to limited space.
Reviews of protocol adherence and source data verification 
were reassuring: the data collected was generally accurate, and 
complete.
During the CMV, we observed that among some studies that 
collected samples the investigator lacked a proper plan for 
longer-term sample and document storage. This is a signifi-
cant challenge that needs to be faced by African institutions for 
their trainees and research teams.
Undertaking research as a post-graduate student or post-doctoral 
researcher is a challenging process with many competing 
demands on trainees’ time. This must have contributed to 
the challenges faced by monitors in scheduling their work. 
Institutional buy-in and a research culture that supports quality 
and rigour in compliance with human subjects research guide-
lines is needed to support an effective internal monitoring 
programme. 
Recommendations
Through the MUII-Plus programme monitoring, we have learnt 
the importance of inducting and training investigators and their 
teams on GCP/GCLP guidelines, the informed consent proc-
ess, and protocols before the research activities begin. We 
urge that Universities and research institutes across Uganda 
and Africa prioritise these trainings to staff and students before 
allowing them to embark on any human research project. 
Institutional research ethics committees should enforce 
GCP/GCLP training as a requirement for project approval.
Conclusions
The MUII-Plus programme’s monitoring model has improved 
the confidence and quality of the research output of the investi-
gators tremendously. Routine site monitoring is a successful tool 
to identify gaps in research training and implementation, and 
improve the quality of research. Research site monitoring should 




LSHTM Data Compass: Internal monitoring within MUII-plus 
for research capacity development. https://doi.org/10.17037/
DATA.000019388
This project contains the following underlying data:
-    Project_monitoring_data_XLSX.xlsx (A dataset contain-
ing data provided by 25 projects for an internal monitoring 
evaluation of the MUII-plus research programme)
Data are available under the terms of the Creative Commons 
Attribution 3.0 Unported license (CC-BY 3.0).
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